VNUS NEWS

Covidien Sued By Samuelson, Wilson and Roe for Disability Discrimination
Date: Jan 28 2010  |  Feed Source: PRWeb

Claimant states that Covidien violated ADA by discriminating against a disabled person.

Samuelson, Wilson & Roe Sues Covidien for Alleged Disability Discrimination
Date: Dec 14 2009  |  Feed Source: PRWeb

Claimant states Covidien discriminated against a disabled person

Published Study Shows VNUS ClosureFAST™ System Significantly Superior to Laser for Varicose Vein Treatment
Date: Jun 10 2009  |  Feed Source: PRWeb

Journal of Vascular & Interventional Radiology Cites Improved Recovery and Quality-of-Life with VNUS Technology

Covidien buys VNUS Medical for $440M - Providence Business News
Date: May 08 2009  |  Feed Source: Google


Covidien Ltd (NYSE:COV) - Acquisition of VNUS to strengthen ... - Research Oracle
Date: May 08 2009  |  Feed Source: Google


VNUS Medical Technologies Inc. Reports Operating Results (10-Q) - GuruFocus.com
Date: May 08 2009  |  Feed Source: Google


Covidien to buy VNUS Medical for $440 million - Forbes
Date: May 08 2009  |  Feed Source: Google


NHS National Innovation Centre Cites VNUS Closure Procedure as Select Innovative Technology
Date: Apr 03 2009  |  Feed Source: PRWeb

Minimally Invasive Treatment for Varicose Veins to be showcased at National Health Service EXPO

VNUS Medical Technologies to Present at UBS Global Life Sciences Conference
PR Newswire

SAN JOSE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the UBS Global Life Sciences Conference, to be held September 22-25, 2008, at the Grand Hyatt Hotel in New York City.

VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
PR Newswire

SAN JOSE, Calif., Aug. 18 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS) corrects its second quarter results and revises its full year 2008 guidance. The Company has recorded adjustments to cost of revenues, operating expenses and certain balance sheet accounts to record additional expenses related to stock-based compensation that were not appropriately recorded in prior periods since the adoption of Statement of Financial Accounting Standard ("SFAS") No. 123R on January 1, 2006. The stock-based compensation adjustments resulted from a correction of a mis-application of forfeiture rates to vested grants by a commercial stock plan administration software application package used by the Company.

 1 2 3 > 

Browse by Category


Browse by Condition